Australia Legal Cannabis Market Size, Share & Trends Report

Australia Legal Cannabis Market Size, Share & Trends Analysis Report By Source (Marijuana, Hemp), By Derivative (CBD, THC), By End-use (Medical Use, Recreational Use, Industrial Use), And Segment Forecasts, 2023 - 2030

  • Report ID: GVR-4-68038-472-7
  • Number of Pages: 100
  • Format: Electronic (PDF)
  • Historical Range: 2016 - 2021
  • Industry: Healthcare

Table of Contents

Chapter 1 Australia Legal Cannabis Market: Methodology and Scope
                   1.1 Market Segmentation
                   1.2 Research Methodology
                       1.2.1 Information Procurement
                   1.3 Information or Data Analysis
                   1.4 Market Formulation & Validation
                       1.4.1 Country Market: CAGR Calculation
                   1.5 Research Methodology
                   1.6 Country Based Segment Share Calculation
                   1.7 List of Secondary Sources
                   1.8 List of Primary Sources
Chapter 2 Australia Legal Cannabis Market: Executive Summary
                   2.1 Market Summary
                   2.2 Segment Summary
                   2.3 Competitive Analysis
Chapter 3 Australia Legal Cannabis Market: Variables, Trends & Scope
                   3.1 Penetration & Growth Prospects Mapping
                   3.2 Australia Legal Cannabis: Market Dynamics
                       3.2.1 Market Driver Analysis
                           3.2.1.1 Rising Patient Population
                           3.2.1.2 Growing Legalization Of Cannabis-Based CBD Products
                           3.2.1.3 Entry Of International Players
                       3.2.2 Market Restraint Analysis
                           3.2.2.1 Stringent Regulations
                           3.2.2.2 Illicit Cannabis Trade
                       3.2.3 Industry Challenge
                           3.2.3.1 Lower market access to cannabis due to absence of legalization programs, leading to smuggling
                           3.2.3.2 Incomplete evidence regarding the effectiveness of medical marijuana
                   3.3 Regulatory Scenario
                       3.3.1 Australia
                           3.3.1.1 Overview
                           3.3.1.2 Cultivation
                           3.3.1.3 Regulatory Bodies Involved
                           3.3.1.4 Import/Export Scenario
                   3.4 Industry Analysis - SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
                       3.4.1 Political And Legal Landscape
                       3.4.2 Economic And Social Landscape
                       3.4.3 Technology Landscape
                   3.5 Industry Analysis - Porter’s Analysis
                       3.5.1 Threat Of New Entrants - Moderate
                       3.5.2 Bargaining Power Of Buyers - Low
                       3.5.3 Bargaining Power Of Suppliers-Moderate
                       3.5.4 Threat Of Substitutes-Moderate
                       3.5.5 Competitive Rivalry-High
                   3.6 Opportunity Analysis
                   3.7 Value Chain Analysis
                       3.7.1 Raw Material Trends
                           3.7.1.1 Market Price Evolution Of Biomass Commodity Cost (To Processor)
                           3.7.1.2 Manufacturing Trends
                   3.8 Australia Legal Cannabis User Pool
                       3.8.1 Estimated Number Of Cannabis Users In Australia From 2016 To 2030
Chapter 4 Australia Legal Cannabis Market: Source Type Estimates & Trend Analysis
                   4.1 Australia Legal Cannabis Market: Source Type Movement Analysis
                       4.1.1 Australia Legal Cannabis Market: Source Type Movement Analysis (2021 & 2030)
                       4.1.2 Hemp
                           4.1.2.1 Hemp market estimates and forecasts, 2016 - 2030 (USD Million)
                           4.1.2.2 Hemp CBD
                               4.1.2.2.1 Hemp CBD market estimates and forecasts, 2016 - 2030 (USD Million)
                           4.1.2.3 Supplements
                               4.1.2.3.1 Supplements market estimates and forecasts, 2016 - 2030 (USD Million)
                           4.1.2.4 Industrial Hemp
                               4.1.2.4.1 Industrial hemp market estimates and forecasts, 2016 - 2030 (USD Million)
                       4.1.3 Marijuana
                           4.1.3.1 Marijuana market estimates and forecasts, 2016 - 2030 (USD Million)
                           4.1.3.2 Flower
                               4.1.3.2.1 Flower market estimates and forecasts, 2016 - 2030 (USD Million)
                           4.1.3.3 Oil & Tinctures
                               4.1.3.3.1 Oil & tinctures market estimates and forecasts, 2016 - 2030 (USD Million)
Chapter 5 Australia Legal Cannabis Market: Derivatives Estimates & Trend Analysis
                   5.1 Australia Legal Cannabis Market: Derivatives Movement Analysis
                       5.1.1 CBD
                           5.1.1.1 CBD market estimates and forecasts, 2016 - 200 (USD Million)
                       5.1.2 THC
                           5.1.2.1 THC market estimates and forecasts, 2016 - 2030 (USD Million)
                       5.1.3 Others
                           5.1.3.1 Others market estimates and forecasts, 2016 - 2030 (USD Million)
Chapter 6 Australia Legal Cannabis Market: End-Use Estimates & Trend Analysis
                   6.1 Australia Legal Cannabis Market: End-Use Movement Analysis
                       6.1.1 Medical Use
                           6.1.1.1 Medical use market estimates and forecasts, 2016 - 200 (USD Million)
                           6.1.1.2 Chronic Pain
                               6.1.1.2.1 Chronic pain market estimates and forecasts, 2016 - 2030 (USD Million)
                           6.1.1.3 Anxiety and Depression
                               6.1.1.3.1 Anxiety and depression market estimates and forecasts, 2016 - 2030 (USD Million)
                           6.1.1.4 Cancer
                               6.1.1.4.1 Cancer market estimates and forecasts, 2016 - 2030 (USD Million)
                           6.1.1.5 Arthritis
                               6.1.1.5.1 Arthritis market estimates and forecasts, 2016 - 2030 (USD Million)
                           6.1.1.6 Diabetes
                               6.1.1.6.1 Diabetes market estimates and forecasts, 2016 - 2030 (USD Million)
                           6.1.1.7 Glaucoma
                               6.1.1.7.1 Glaucoma market estimates and forecasts, 2016 - 2030 (USD Million)
                           6.1.1.8 Migraines
                               6.1.1.8.1 Migraines market estimates and forecasts, 2016 - 2030 (USD Million)
                           6.1.1.9 Epilepsy
                               6.1.1.9.1 Epilepsy market estimates and forecasts, 2016 - 2030 (USD Million)
                           6.1.1.10 Multiple Sclerosis
                               6.1.1.10.1 Multiple sclerosis market estimates and forecasts, 2016 - 2030 (USD Million)
                           6.1.1.11 AIDS
                               6.1.1.11.1 AIDS market estimates and forecasts, 2016 - 2030 (USD Million)
                           6.1.1.12 Amyotrophic Lateral Sclerosis
                               6.1.1.12.1 Amyotrophic Lateral Sclerosis market estimates and forecasts, 2016 - 2030 (USD Million)
                           6.1.1.13 Alzheimer’s
                               6.1.1.13.1 Alzheimer’s market estimates and forecasts, 2016 - 2030 (USD Million)
                           6.1.1.14 Post Traumatic Stress Disorder
                               6.1.1.14.1 Post Traumatic Stress Disorder market estimates and forecasts, 2016 - 2030 (USD Million)
                           6.1.1.15 Parkinson’s
                               6.1.1.15.1 Parkinson’s market estimates and forecasts, 2016 - 2030 (USD Million)
                           6.1.1.16 Tourette’s
                               6.1.1.16.1 Tourette’s market estimates and forecasts, 2016 - 2030 (USD Million)
                           6.1.1.17 Others
                               6.1.1.17.1 Others market estimates and forecasts, 2016 - 2030 (USD Million)
                       6.1.2 Industrial Use
                           6.1.2.1 Industrial use market estimates and forecasts, 2016 - 2030 (USD Million)
Chapter 7 Competitive Landscape
                   7.1 Company Profiles: ASX Listed Cannabis Companies
                       7.1.1 AusCann Group Holdings Ltd
                           7.1.1.1 Company overview
                           7.1.1.2 Financial performance
                           7.1.1.3 Product benchmarking
                           7.1.1.4 Strategic initiatives
                       7.1.2 Cann Group Limited
                           7.1.2.1 Company overview
                           7.1.2.2 Product benchmarking
                           7.1.2.3 Financial performance
                           7.1.2.4 Strategic initiatives
                       7.1.3 Bod Australia
                           7.1.3.1 Company overview
                           7.1.3.2 Financial performance
                           7.1.3.3 Product benchmarking
                           7.1.3.4 Strategic initiatives
                       7.1.4 Zelira Therapeutics
                           7.1.4.1 Company overview
                           7.1.4.2 Product benchmarking
                           7.1.4.3 Strategic initiatives
                       7.1.5 Althea Group
                           7.1.5.1 Company overview
                           7.1.5.2 Financial performance
                           7.1.5.3 Product benchmarking
                           7.1.5.4 Strategic initiatives
                       7.1.6 EPSILON
                           7.1.7.1 Company overview
                           7.1.7.2 Financial performance
                           7.1.7.3 Product benchmarking
                           7.1.7.4 Strategic initiatives
                       7.1.7 MCG Pharma
                           7.1.7.1 Company overview
                           7.1.7.2 Financial performance
                           7.1.7.3 Product benchmarking
                           7.1.7.4 Strategic initiatives
                       7.1.8 ECOFIBRE
                           7.1.8.1 Company overview
                           7.1.8.2 Financial performance
                           7.1.8.3 Product benchmarking
                           7.1.8.4 Strategic initiatives
                       7.1.9 Little Green Pharma
                           7.1.9.1 Company overview
                           7.1.9.2 Financial performance
                           7.1.9.3 Product benchmarking
                           7.1.9.4 Strategic initiatives
                       7.1.10 Epsilon Healthcare Limited
                           7.1.10.1 Company overview
                           7.1.10.2 Financial performance
                           7.1.10.3 Product benchmarking
                           7.1.10.4 Strategic initiatives
                       7.1.11 Emyria
                           7.1.11.1 Company overview
                           7.1.11.2 Financial performance
                           7.1.11.3 Product benchmarking
                           7.1.11.4 Strategic initiatives


List of Tables

TABLE 1 List of secondary data sources
TABLE 2 List of primary sources
TABLE 3 Estimated number of cannabis users, 2016 - 2030
TABLE 4 Australia legal cannabis market, by product type, 2016 - 2030 (USD Million)
TABLE 5 Australia marijuana market, by product, 2016 - 2030 (USD Million)
TABLE 6 Australia hemp market, by product, 2016 - 2028 (USD Million)
TABLE 7 Australia legal cannabis market, by end-use, 2016 - 2030 (USD Million)
TABLE 8 Australia legal cannabis end-use market, by medical application, 2016 - 2030 (USD Million)


List of Figures

FIG. 1 Market segmentation
FIG. 2 Market research process
FIG. 3 Information procurement
FIG. 4 Primary research pattern
FIG. 5 Market research approaches
FIG. 6 Value chain-based sizing & forecasting
FIG. 7 QFD modeling for market share assessment
FIG. 8 Market formulation & validation
FIG. 9 Australia legal cannabis market snapshot, 2021 (USD Million)
FIG. 10 Penetration & growth prospects mapping
FIG. 11 Australia legal cannabis market driver impact
FIG. 12 Australia legal cannabis market restraint impact
FIG. 13 Opportunity analysis
FIG. 14 Australia legal cannabis market, source type outlook: Key takeaways
FIG. 15 Australia legal cannabis market: Source type movement analysis (2021 & 2030) (USD Million)
FIG. 16 Hemp market estimates and forecasts, 2016 - 2030 (USD Million)
FIG. 17 Hemp CBD market estimates and forecasts, 2016 - 2030 (USD Million)
FIG. 18 Supplements market estimates and forecasts, 2016 - 2030 (USD Million)
FIG. 19 Industrial hemp market estimates and forecasts, 2016 - 2030 (USD Million)
FIG. 20 Marijuana market estimates and forecasts, 2016 - 2030 (USD Million)
FIG. 21 Flower market estimates and forecasts, 2016 - 2030 (USD Million)
FIG. 22 Oil & tinctures market estimates and forecasts, 2016 - 2030 (USD Million)
FIG. 23 Australia legal cannabis market, application outlook: Key takeaways
FIG. 24 Australia legal cannabis market: Application movement analysis (2021 & 2030)
FIG. 25 Medical use market estimates and forecasts, 2016 - 2030 (USD Million)
FIG. 26 Chronic pain market estimates and forecasts, 2016 - 2030 (USD Million)
FIG. 27 Anxiety market estimates and forecasts, 2016 - 2030 (USD Million)
FIG. 28 Inflammation market estimates and forecasts, 2016 - 2030 (USD Million)
FIG. 29 Sleep Disorders market estimates and forecasts, 2016 - 2030 (USD Million)
FIG. 30 Others market estimates and forecasts, 2016 - 2030 (USD Million)
FIG. 31 Industrial use market estimates and forecasts, 2016 - 2030 (USD Million)

What questions do you have? Get quick response from our industry experts. Request a Free Consultation
pdf

GET A FREE SAMPLE

bck

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.

cog

NEED A CUSTOM REPORT?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.

Contact us now to get our best pricing.

esomar icon

ESOMAR certified & member

ISO

ISO Certified

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.

great place to work icon